QuiVad

Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 6.24% on October 25, 2019. The shaded band is the year shown above.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

689 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 3, 2025Qube Research & Technologies Ltd.0.47%still open
March 28, 2025Citadel Advisors LLC0.50%still open
March 21, 2025Marshall Wace LLP0.59%still open
March 10, 2025Qube Research & Technologies Ltd.1.20%still open
March 3, 2025Arrowstreet Capital, Limited Partnership0.88%still open
February 24, 2025Arrowstreet Capital, Limited Partnership0.98%still open
February 21, 2025Connor, Clark & Lunn Investment Management Ltd.0.49%still open
February 20, 2025Arrowstreet Capital, Limited Partnership1.06%still open
February 20, 2025Marshall Wace LLP0.61%still open
February 17, 2025Marshall Wace LLP0.58%still open
February 13, 2025Qube Research & Technologies Ltd.1.12%still open
February 13, 2025Marshall Wace LLP0.63%still open
February 12, 2025Connor, Clark & Lunn Investment Management Ltd.0.50%still open
February 5, 2025WorldQuant, LLC0.48%still open
February 4, 2025Marshall Wace LLP0.50%still open
January 29, 2025WorldQuant, LLC0.51%still open
January 16, 2025Qube Research & Technologies Ltd.1.00%still open
January 13, 2025Qube Research & Technologies Ltd.0.90%still open
January 10, 2025Qube Research & Technologies Ltd.0.86%still open
January 7, 2025Arrowstreet Capital, Limited Partnership1.19%still open
December 30, 2024Qube Research & Technologies Ltd.0.71%still open
December 27, 2024Qube Research & Technologies Ltd.0.69%still open
December 19, 2024Arrowstreet Capital, Limited Partnership1.20%still open
December 19, 2024Qube Research & Technologies Ltd.0.71%still open
November 20, 2024Qube Research & Technologies Ltd.0.61%still open
November 15, 2024Qube Research & Technologies Ltd.0.51%still open
November 7, 2024Qube Research & Technologies Ltd.0.49%still open
November 4, 2024Qube Research & Technologies Ltd.0.50%still open
October 29, 2024Arrowstreet Capital, Limited Partnership1.19%still open
September 12, 2024Arrowstreet Capital, Limited Partnership1.27%still open
August 13, 2024Arrowstreet Capital, Limited Partnership1.39%still open
June 25, 2024Arrowstreet Capital, Limited Partnership1.49%still open
November 16, 2023Qube Research & Technologies Ltd.0.49%still open
November 15, 2023Qube Research & Technologies Ltd.0.50%still open
November 9, 2023Qube Research & Technologies Ltd.0.49%still open
November 7, 2023Qube Research & Technologies Ltd.0.51%still open
October 30, 2023Qube Research & Technologies Ltd.0.49%still open
September 18, 2023Qube Research & Technologies Ltd.0.50%still open
September 15, 2023Qube Research & Technologies Ltd.0.49%still open
September 6, 2023Qube Research & Technologies Ltd.0.51%still open
September 4, 2023Qube Research & Technologies Ltd.0.49%still open
September 1, 2023Qube Research & Technologies Ltd.0.50%still open
August 31, 2023Arrowstreet Capital, Limited Partnership1.56%still open
August 29, 2023Qube Research & Technologies Ltd.0.49%still open
August 24, 2023Qube Research & Technologies Ltd.0.50%still open
August 23, 2023Qube Research & Technologies Ltd.0.48%still open
August 7, 2023Qube Research & Technologies Ltd.0.51%still open
July 31, 2023Qube Research & Technologies Ltd.0.48%still open
July 7, 2023Qube Research & Technologies Ltd.0.59%still open
July 5, 2023AHL Partners LLP0.49%still open

Other companies sold short in the Netherlands

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=2